Table 1.
Clinical characteristics of 232 enrolled patients
| Underlying disease/condition | No. | % |
|---|---|---|
| Hematological patients | 113 | 48.7 |
| Hematological malignancya | ||
| AML | 63 | 55.7 |
| ALL | 19 | 16.8 |
| NHL | 12 | 10.6 |
| CLL | 8 | 7.1 |
| MM | 8 | 7.1 |
| CML | 2 | 1.8 |
| HD | 1 | 0.9 |
| Non-hematological patients | 119 | 51.3 |
| Lung disease | 28 | 23.5 |
| COPD | 13 | 76.4 |
| Tuberculosis | 9 | 32.1 |
| Cystic fibrosis | 2 | 7.1 |
| Idiopathic fibrosis | 2 | 7.1 |
| Pulmonary emphysema | 1 | 3.6 |
| Pleuritis | 1 | 3.6 |
| Solid cancer | 20 | 16.8 |
| Lung | 9 | 45.0 |
| Intestine | 5 | 25.0 |
| Brain | 3 | 15.0 |
| Liver | 1 | 5.0 |
| Mouth | 1 | 5.0 |
| Heart | 1 | 5.0 |
| Organ transplantation | 14 | 11.7 |
| Lung | 5 | 35.7 |
| Kidney | 5 | 35.7 |
| Liver | 4 | 28.6 |
| Trauma | 13 | 10.9 |
| Surgery | 9 | 7.6 |
| Diabetes | 8 | 6.7 |
| HIV/AIDS | 8 | 6.7 |
| Autoimmune disorder | 7 | 5.9 |
| Cirrhosis | 4 | 3.4 |
| Burn | 3 | 2.5 |
| Renal disease | 2 | 1.7 |
| Otherb | 3 | 2.5 |
AML acute myeloid leukemia, ALL acute lymphoid leukemia, CLL chronic lymphocytic leukemia, CML chronic myeloid leukemia, NHL non-Hodgkin’s lymphoma, HD Hodgkin’s disease, MM multiple myeloma, COPD chronic obstructive pulmonary disease
aThirty-one patients underwent transplantation are included in this group
bAplastic anemia (n = 1); chronic granulomatous disease (n = 1); no risk factor (n = 1)